History
# Registration date Revision Id
2 2023-04-27, 1402/02/07 263252
1 2021-11-29, 1400/09/08 207231
Changes made to previous revision
  • Help:

    Red color represents old content. It may be empty showing addition in the new version.
    Green color represents new content. It may be empty showing deletion in the new version.

    Inline Side by side
    Added new contents, deleted old contents, contents that are not changed.
    New table contents New table contents
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    Added new contents, contents that are not changed.
    Deleted old contents, contents that are not changed.
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    New table contents New table contents
    Unchanged contents Unchanged contents
  • Protocol summary

    Study the effect of dexamethasone and bupivacaine pre-peritoneal injection at the site of laparoscopic ports, on complications after laparoscopic cholecystectomy in Isfahan in 1400
    Study the effect of dexamethasone and bupivacaine pre-peritoneal injection at the site of laparoscopic ports, on complications after laparoscopic cholecystectomy
    تعیین تاثیر تزریق لوکال دگزامتازون به همراه بوپیواکایین در محل پورت های لاپاراسکوپی به صورت پره پریتونئال بر روی عوارض بعد از عمل کله سیستکتومی لاپاراسکوپیک در مراکز آموزشی درمانی اصفهان در سال 1400
    تعیین تاثیر تزریق لوکال دگزامتازون به همراه بوپیواکایین در محل پورت های لاپاراسکوپی به صورت پره پریتونئال بر روی عوارض بعد از عمل کله سیستکتومی لاپاراسکوپیک
    Clinical trial, with control group, with parallel groups, three-way blind, randomized, phase 3 on 96 patients. Random numbers method which carried out at an external site (miraclesalad) is used for randomization.
    Randomized parallel phase 3 placebo-controlled triple-blinded clinical trial study
    کارآزمایی بالینی دارای گروه کنترل، با گروه های موازی، سه سویه کور، تصادفی شده، فاز 3 برروی 96 بیمار. برای تصادفی از روش اعداد تصادفی با استفاده از وبسایت (میراکل سالاد) استفاده میشود.
    کارآزمایی بالینی تصادفی شده و موازی دارای گروه کنترل و سه سویه کور فاز 3
    In order to evaluate the effect of bupivacaine with and without dexamethasone on pain after laparoscopic cholecystectomy in the operating room by one of the trained technicians without informing patients and surgeon and researcher in one group bupivacaine + dexamethasone injection and in the other group bupivacaine It is performed alone and in the first 24 hours, the amount of pain and the need for pain in patients is evaluated.
    In order to evaluate the effect of bupivacaine with and without dexamethasone on pain after laparoscopic cholecystectomy, in the operating room by one of the trained technicians without informing any involved researcher and investigator, in one group of bupivacaine + dexamethasone and in the other group bupivacaine+ the same amount of normal saline is prepared and injected. The severity of postoperative pain, the rate of opium usage for pain control, and the rates of nausea and vomiting are investigated.
    در این مطالعه ما به بررسی اثر بوپیواکائین همراه و بدون دگزامتازون بر میزان درد پس از کوله سیستکتومی لاپاروسکوپیک میپردازیم؛ بدین منظور، در اتاق عمل توسط یکی از تکنسین های آموزش دیده ، بدون اطلاع بیماران و جراح و محقق، ما در یک گروه بوپیواکائین+دگزامتازون و در گروه دیگر فقط بوپیواکائین تزریق میکنیم. در 24 ساعت اول، میزان درد و نیاز به مسکن در بیماران ارزیابی میگردد.
    در این مطالعه ما به بررسی اثر بوپیواکائین همراه و بدون دگزامتازون بر میزان درد پس از کوله سیستکتومی لاپاروسکوپیک میپردازیم؛ بدین منظور، در اتاق عمل توسط یکی از تکنسین های آموزش دیده ، بدون اطلاع محققین دخیل در طرح، ما در یک گروه بوپیواکائین+دگزامتازون و در گروه دیگر بوپیواکائین وبه همان میزان مساوی دگزامتازون از نرمال سالین تزریق میکنیم. بعد از عمل میزان درد و نیاز به مخدر به علاوه تهوع و استفراغ ارزیابی میگردد.
    The inclusion criteria is all the patients undergoing laparoscopic cholecystectomy with a diagnosis of biliary colic or chronic cholecystitis in 1400. Criteria for not including patients in our study are: diagnosis of acute cholecystitis along with findings such as, leukocytosis and high ESR and CRP, gangrene, empyema and evidence of bile in the abdominal cavity during surgery, known allergy to local anesthetics, open surgery and diabetic patients and those with dirty wounds and open cholecystectomy.
    The inclusion criteria are all patients undergoing laparoscopic cholecystectomy diagnosed with biliary colic or chronic cholecystitis. Criteria for not including patients in our study are the diagnosis of acute cholecystitis along with findings such as leukocytosis and high ESR and CRP, gangrene, empyema and evidence of bile in the abdominal cavity during surgery, known allergy to local anesthetics, open surgery and diabetic patients and those with dirty wounds and open cholecystectomy.
    معیار ورود بیماران، قرارگرفتن تحت عمل کله سیستکتومی لاپاروسکوپیک با تشخیص بیلیاری کولیک یا کوله سیستیت مزمن در سال 1400 می باشد. معیار عدم ورود بیماران از مطالعه ما، تشخیص کله سیستیت حاد با یافته هایی همچون لوکوسیتوز و ESR و CRP بالا، مشاهده گانگرن، امپیم و شواهد وجود صفرا در حفره شکم حین عمل، وجود آلرژی شناخته شده به بی حس کننده های موضعی، تبدیل عمل به کوله سیستکتومی باز، بیماران دارای ضعف ایمنی و دیابتی و مواردی که حین عمل الودگی زخم دارند می باشد.
    معیار ورود بیماران، قرارگرفتن تحت عمل کله سیستکتومی لاپاروسکوپیک با تشخیص بیلیاری کولیک یا کوله سیستیت مزمن می باشد. معیار عدم ورود بیماران از مطالعه ما، تشخیص کله سیستیت حاد با یافته هایی همچون لوکوسیتوز و ESR و CRP بالا، مشاهده گانگرن، امپیم و شواهد وجود صفرا در حفره شکم حین عمل، وجود آلرژی شناخته شده به بی حس کننده های موضعی، تبدیل عمل به کوله سیستکتومی باز، بیماران دارای ضعف ایمنی و دیابتی و مواردی که حین عمل الودگی زخم دارند می باشد.
    7 mg bupivacaine is injected at the lower ports and 3 mg bupivacaine at the upper ports. Then, only in the "bupivacaine + dexamethasone" group, the dose of dexamethasone is determined based on the patient's weight at 0.2 mg per kg and is divided into four parts, and each part is injected at the site of a port.
    In the intervention group, the dose of dexamethasone is 0.2 mg per kg of body weight. It is divided into four parts, and each part is injected around each trocar. For bupivacaine, 7 mg is injected at the lower ports and 3 mg at the upper ports. For a placebo, the same amount of normal saline based on the dexamethasone formula is mixed and injected.
    در محل پورت های تحتانی7 میلی گرم بوپیواکایین و در محل پورت های فوقانی 3 میلی گرم بوپیواکایین تزریق می شود . سپس تنها در گروه «بوپیواکایین+دگزامتازون»، دوز دگزامتازون بر اساس وزن بیمار به میزان 0.2میلیگرم به ازای هر کیلوگرم تعیین و به چهار قسمت تقسیم می شود و هر قسمت در محل یک پورت تزریق می گردد.
    در گروه مداخله دگزامتازون به میزان 0.2 میلیگرم به ازای هر کیلوگرم از وزن بدن تعیین و به چهار قسمت تقسیم می شود و هر قسمت در محل یک تروکار و در اطراف پورت تزریق می گردد. بوپیواکایین به میزان ۷ میلی گرم در محل پورت های تحتانی و 3 میلی گرم در محل پورتهای فوقانی تزریق می شود . طبق وزن و فرمولی که برای گروه مداخله در نظر داریم از نرمال سالین به جای دگزامتازون استفاده خواهد شد.
    Frequency of nausea and vomiting, relative pain intensity, mean of drug use and mean of BS after 24 hours in the two groups.
    The severity of postoperative pain, rates of opium usage for pain control, nausea, and vomiting
    دفعات تهوع و استفراغ، شدت نسبی درد، میانگین میزان استفاده از داروهای مخدر و میانگین میزان BS بیماران پس از 24 ساعت در دو گروه مورد مطالعه
    شدت درد بعد از عمل، مصرف مخدر برای کنترل درد، میزان بروز تهوع و استفراغ بعد از عمل
  • General information

    Not used
    Used
    empty
    104
    2021-11-22, 1400/09/01
    2021-11-30, 1400/09/09
    2022-03-21, 1401/01/01
    2022-04-21, 1401/02/01
    empty
    2021-11-30, 1400/09/09
    empty
    2022-04-30, 1401/02/10
    empty
    2022-08-23, 1401/06/01
    empty
    Trial ending and updating information
    empty
    پایان ترایال و به روز رسانی اطلاعات
    بررسی تاثیر تزریق لوکال دگزامتازون به همراه بوپیواکایین در محل پورت های لاپاراسکوپی به صورت پره پریتونئال بر روی عوارض بعد از عمل کله سیستکتومی لاپاراسکوپیک، یک کارآزمایی بالینی تصادفی
    بررسی تاثیر تزریق موضعی دگزامتازون به همراه بوپیواکایین در محل پورت های لاپاراسکوپی به صورت پره پریتونئال بر روی عوارض بعد از عمل کله سیستکتومی لاپاراسکوپیک، یک کارآزمایی بالینی تصادفی
    Patients will be randomly divided into two groups using computer random number method. This random distribution of patients will be done by an independent computer programmer using www.randomization.com.
    Patients will be randomly divided into two groups using the computer random-generated number method. This random distribution of patients will be done by an independent computer programmer using www.randomization.com.
    بیماران با استفاده از روش اعداد تصادفی رایانه ای به طور تصادفی به دو گروه تقسیم خواهند شد. این توزیع تصادفی بیماران توسط یک برنامه نویس رایانه ای مستقل با استفاده از پایگاه www.randomization.com انجام خواهد شد.
    بیماران با استفاده از تصادفی سازی رایانه ای به طور تصادفی به دو گروه تقسیم خواهند شد. این توزیع تصادفی بیماران توسط یک برنامه نویس رایانه ای مستقل با استفاده از پایگاه www.randomization.com انجام خواهد شد.
  • Secondary outcomes

    #1
    The need for drugs and analgesics
    The need for opium and analgesics
    #2
    Frequency of nausea, vomiting and diabetes in the patient within 24 hours after surgery
    Frequency of nausea, vomiting within 24 hours after surgery
    دفعات تهوع و استفراغ و قند بیمار طی 24 ساعت پس از جراحی
    دفعات تهوع و استفراغ بیمار طی 24 ساعت پس از جراحی
  • Intervention groups

    #1
    Prevention
    Treatment - Drugs
    Intervention group1: After induction of general anesthesia and surgery, a peritoneal injection will be performed at the incision site of the trochanter under the direct guidance of a laparoscopic camera with Branol 18. In the "bupivacaine + dexamethasone" group, 7 mg bupivacaine is injected at the lower ports and 3 mg bupivacaine at the upper ports. The dose of dexamethasone is then determined based on the patient's weight at 0.2 mg per kg and divided into four parts and each part is injected at the site of a port.
    Intervention group 1: After induction of general anesthesia and surgery, a peritoneal injection will be performed at the incision site of the trocars under the direct guidance of a laparoscopic camera with No. 18 branul. In the "bupivacaine + dexamethasone" group, 7 mg bupivacaine is injected at the lower ports and 3 mg bupivacaine at the upper ports. The dose of dexamethasone is then determined based on the patient's weight at 0.2 mg per kg and divided into four parts and each part is injected at the site of a port.
    #2
    Prevention
    Placebo
    Intervention group2:In the bupivacaine group alone, 7 mg bupivacaine will be injected at the lower ports and 3 mg bupivacaine at the upper ports.:
    For intervention group 2: In the bupivacaine group alone, 7 mg bupivacaine will be injected at the lower ports and 3 mg bupivacaine at the upper ports. For the placebo, based on the formula used for dexamethasone and body weight, sterile injectable normal saline is used.
    گروه مداخله دوم: در گروه «بوپیواکایین تنها»، در محل پورت های تحتانی 7 میلی گرم بوپیواکایین و در محل پورت های فوقانی 3 میلی گرم بوپیواکایین تزریق خواهد شد.
    گروه مداخله دوم: در گروه «بوپیواکایین تنها»، در محل پورت های تحتانی 7 میلی گرم بوپیواکایین و در محل پورت های فوقانی 3 میلی گرم بوپیواکایین تزریق خواهد شد. طبق فرمولی که برای دگزامتازون داشتیم و بر اساس وزن بدن به جای دگزامتازون در گروه کنترل از همان حجم نرمال سالین استریل قابل تزریق استفاده خواهد شد.

Protocol summary

Study aim
Study the effect of dexamethasone and bupivacaine pre-peritoneal injection at the site of laparoscopic ports, on complications after laparoscopic cholecystectomy
Design
Randomized parallel phase 3 placebo-controlled triple-blinded clinical trial study
Settings and conduct
In order to evaluate the effect of bupivacaine with and without dexamethasone on pain after laparoscopic cholecystectomy, in the operating room by one of the trained technicians without informing any involved researcher and investigator, in one group of bupivacaine + dexamethasone and in the other group bupivacaine+ the same amount of normal saline is prepared and injected. The severity of postoperative pain, the rate of opium usage for pain control, and the rates of nausea and vomiting are investigated.
Participants/Inclusion and exclusion criteria
The inclusion criteria are all patients undergoing laparoscopic cholecystectomy diagnosed with biliary colic or chronic cholecystitis. Criteria for not including patients in our study are the diagnosis of acute cholecystitis along with findings such as leukocytosis and high ESR and CRP, gangrene, empyema and evidence of bile in the abdominal cavity during surgery, known allergy to local anesthetics, open surgery and diabetic patients and those with dirty wounds and open cholecystectomy.
Intervention groups
In the intervention group, the dose of dexamethasone is 0.2 mg per kg of body weight. It is divided into four parts, and each part is injected around each trocar. For bupivacaine, 7 mg is injected at the lower ports and 3 mg at the upper ports. For a placebo, the same amount of normal saline based on the dexamethasone formula is mixed and injected.
Main outcome variables
The severity of postoperative pain, rates of opium usage for pain control, nausea, and vomiting

General information

Reason for update
Trial ending and updating information
Acronym
IRCT registration information
IRCT registration number: IRCT20211008052699N1
Registration date: 2021-11-29, 1400/09/08
Registration timing: prospective

Last update: 2023-04-30, 1402/02/10
Update count: 1
Registration date
2021-11-29, 1400/09/08
Registrant information
Name
Mohammad Eslamian
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 31 3620 2020
Email address
mr.esl67@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2021-11-30, 1400/09/09
Expected recruitment end date
2022-04-21, 1401/02/01
Actual recruitment start date
2021-11-30, 1400/09/09
Actual recruitment end date
2022-04-30, 1401/02/10
Trial completion date
2022-08-23, 1401/06/01
Scientific title
Evaluation of the effect of local injection of dexamethasone with bupivacaine at pre-peritoneal laparoscopic ports on laparoscopic complications after laparoscopic cholecystectomy a randomized controlled clinical trial.
Public title
Evaluation of dexamethasone injection on complications after gallbladder surgery
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria:
Laparoscopic cholecystectomy with diagnosis of biliary colic or chronic cholecystitis
Exclusion criteria:
Acute cholecystitis Presence of leukocytosis or high ESR, CRP Gangrene, empyema and evidence of bile in the abdominal cavity during surgery Known allergies to local anesthetics History of chronic pain following the use of common narcotics Open cholecystectomy Patients with immunodeficiency and diabetes Cases that have dirty wounds during the operation
Age
From 18 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Investigator
  • Outcome assessor
  • Data and Safety Monitoring Board
Sample size
Target sample size: 96
Actual sample size reached: 104
Randomization (investigator's opinion)
Randomized
Randomization description
Patients will be randomly divided into two groups using the computer random-generated number method. This random distribution of patients will be done by an independent computer programmer using www.randomization.com.
Blinding (investigator's opinion)
Triple blinded
Blinding description
On the day of surgery, one of the operating room technicians trained according to the instructions and based on the site www.randomization.com prepares the medicine for the group in which the patient is accidentally placed and then the surgeon injects it only without notice to the relevant place. Dexamethasone and bupivacaine are injected into a syringe, and to hide the volume of the drug, the syringes are covered with a dark coating and the syringe is identified only based on groups A and B. Slowly The patient and the data collector and the safety and data monitoring committee also do not know what the drug was.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Isfahan University of Medical Sciences
Street address
Isfahan University of Medical sciences., Hezarjarib St., Azadi Sq
City
Isfahan
Province
Isfehan
Postal code
8174673461
Approval date
2021-10-03, 1400/07/11
Ethics committee reference number
IR.MUI.MED.REC.1400.546

Health conditions studied

1

Description of health condition studied
Chronic cholecystitis
ICD-10 code
K81.1
ICD-10 code description
Chronic cholecystitis

2

Description of health condition studied
Postprocedural pain
ICD-10 code
G89.18
ICD-10 code description
Other acute postprocedural pain

Primary outcomes

1

Description
Pain intensity based on VAS the first 24 hours after surgery
Timepoint
24 hours after the surgery
Method of measurement
Visual analog scale

Secondary outcomes

1

Description
The need for opium and analgesics
Timepoint
24 hours after the surgery
Method of measurement
Medical records

2

Description
Frequency of nausea, vomiting within 24 hours after surgery
Timepoint
24 hours after the surgery
Method of measurement
Medical records

Intervention groups

1

Description
Intervention group 1: After induction of general anesthesia and surgery, a peritoneal injection will be performed at the incision site of the trocars under the direct guidance of a laparoscopic camera with No. 18 branul. In the "bupivacaine + dexamethasone" group, 7 mg bupivacaine is injected at the lower ports and 3 mg bupivacaine at the upper ports. The dose of dexamethasone is then determined based on the patient's weight at 0.2 mg per kg and divided into four parts and each part is injected at the site of a port.
Category
Treatment - Drugs

2

Description
For intervention group 2: In the bupivacaine group alone, 7 mg bupivacaine will be injected at the lower ports and 3 mg bupivacaine at the upper ports. For the placebo, based on the formula used for dexamethasone and body weight, sterile injectable normal saline is used.
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Amin hospital
Full name of responsible person
Hamid Melali
Street address
Sonbolestan St, Ebn-Sina Ave
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3445 5051
Email
dean@med.mui.ac.ir

2

Recruitment center
Name of recruitment center
Al-Zahra hospital
Full name of responsible person
Mohammad Rezavanian
Street address
Soffe Blv
City
Isfahan
Province
Isfehan
Postal code
8174675731
Phone
+98 31 3620 2020
Email
alzahra@mui.ac.ir

3

Recruitment center
Name of recruitment center
Seyyed-al-shohada hospital
Full name of responsible person
Maryam Haghighat
Street address
Motahari Ave
City
Isfahan
Province
Isfehan
Postal code
8174675731
Phone
+98 31 3235 0210
Email
dean@med.mui.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Dr Shaghayegh Haghjoo Javanmard
Street address
N. 4, Isfahan university oh medical science, Hezarjarib St
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 8663 8318
Email
research@mui.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Esfahan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Mohammad Eslamian
Position
Assistant Professor
Latest degree
Specialist
Other areas of specialty/work
General Surgery
Street address
Soffeh Blvd, Al-Zahra hospital
City
Isfahan
Province
Isfehan
Postal code
8174675731
Phone
+98 31 3620 2020
Fax
Email
mr.esl67@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Mohammad Eslamian
Position
Assistant Professor
Latest degree
Specialist
Other areas of specialty/work
General Surgery
Street address
Soffeh Blvd, Al-Zahra hospital
City
Isfahan
Province
Isfehan
Postal code
8174675731
Phone
+98 31 3620 2020
Fax
Email
mr.esl67@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Mohammad Eslamian
Position
Assistant Professor
Latest degree
Specialist
Other areas of specialty/work
General Surgery
Street address
Soffeh Blvd, Al-Zahra hospital
City
Isfahan
Province
Isfehan
Postal code
8174675731
Phone
+98 31 3620 2020
Fax
Email
mr.esl67@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...